Atsushi Kasamatsu
Overview
Explore the profile of Atsushi Kasamatsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
1682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuneizumi K, Kasamatsu A, Saito T, Fukushima R, Taga Y, Mizuno K, et al.
Biochem Biophys Rep
. 2024 Aug;
39:101790.
PMID: 39156722
Lysyl hydroxylase 2 (LH2) catalyzes the hydroxylation of lysine residues in the telopeptides of type I collagen. This modification is critical for the formation of stable hydroxylysine-aldehyde derived collagen cross-links,...
2.
Kasamatsu A, Nozaki R, Kawasaki K, Saito T, Minemura C, Seki N, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539573
microRNAs (miRs) function in cancer progression as post-transcriptional regulators. We previously reported that endogenous circular RNAs (circRNAs) function as efficient miR sponges and could act as novel gene regulators in...
3.
Otsuru M, Yanamoto S, Yamada S, Nakashiro K, Harazono Y, Kohgo T, et al.
Int J Environ Res Public Health
. 2023 Mar;
20(5).
PMID: 36901553
There are a few reports that focus on radiotherapy (RT) and cetuximab (CET) therapy exclusively for oral cancer. This retrospective study aimed to investigate the efficacy and safety of RT...
4.
Kasamatsu A, Fukushima R, Nakamura K, Kawasaki K, Yoshimura S, Koyama T, et al.
Biochem Biophys Rep
. 2022 Nov;
32:101385.
PMID: 36386443
Radiotherapy (RT) for head and neck cancer results in irreversible damage to salivary glands (SGs) and decreases saliva production, leading to a dry mouth. To date, there are no satisfactory...
5.
Saito T, Asai S, Tanaka N, Nohata N, Minemura C, Koma A, et al.
Int J Mol Sci
. 2022 Aug;
23(16).
PMID: 36012427
Advanced-stage oral squamous cell carcinoma (OSCC) patients are treated with combination therapies, such as surgery, radiation, chemotherapy, and immunotherapy. However, OSCC cells acquire resistance to these treatments, resulting in local...
6.
Minemura C, Asai S, Koma A, Kikkawa N, Kato M, Kasamatsu A, et al.
Genes (Basel)
. 2022 Jul;
13(7).
PMID: 35886008
Analysis of microRNA (miRNA) expression signatures in head and neck squamous cell carcinoma (HNSCC) has revealed that the miR-30 family is frequently downregulated in cancer tissues. The Cancer Genome Atlas...
7.
Minemura C, Asai S, Koma A, Kase-Kato I, Tanaka N, Kikkawa N, et al.
Int J Mol Sci
. 2022 Apr;
23(7).
PMID: 35409173
Recently, our studies revealed that some passenger strands of microRNAs (miRNAs) were closely involved in cancer pathogenesis. Analysis of miRNA expression signatures showed that the expression of miR-30e-3p (the passenger...
8.
Nobuchi T, Saito T, Kasamatsu A, Kawasaki K, Nozaki R, Kase Y, et al.
Biochem Biophys Res Commun
. 2022 Feb;
597:115-121.
PMID: 35134609
Radiotherapy is commonly used to treat oral squamous cell carcinoma (OSCC), and radioresistance is a critical factor resulting in poor outcomes. Several genes have been reported to be therapeutic targets...
9.
Komatsu M, Saito K, Miyamoto I, Koike K, Iyoda M, Nakashima D, et al.
Oncol Lett
. 2022 Jan;
23(2):49.
PMID: 34992682
GTPases of immunity-associated protein 2 (GIMAP2) is a GTPase family member associated with T cell survival. However, its mechanisms of action in oral squamous cell carcinoma (OSCC) remain largely unknown....
10.
Tanaka N, Minemura C, Asai S, Kikkawa N, Kinoshita T, Oshima S, et al.
Genes (Basel)
. 2021 Dec;
12(12).
PMID: 34946859
Our previous study revealed that the family (/ and /) acts as tumor-suppressive miRNAs in head and neck squamous cell carcinoma (HNSCC). Furthermore, recent studies have indicated that the passenger...